ArticleAnti-cancer drugs2025

Iruplinalkib for G1202R-mutant non-small cell lung cancer with anaplastic lymphoma kinase double fusion failed to alectinib: a case report.

Guangjian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.